Drug recall · December 17, 2025
Sertraline Hydrochloride Tablets USP recall
Why: Defective container - seal not adhering to bottles
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.
- Lots / codes
Lot # QB00865, exp. date Feb 2028
- Quantity
- 52,128 bottles
- Company
- Lupin Pharmaceuticals Inc., Naples, FL
- Distribution
- Nationwide.
- Initiated
- November 5, 2025 · Voluntary: Firm initiated
- Classified
- December 10, 2025
- Reported
- December 17, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sertraline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.